OP2 Organizational Impact Model Associated With Switching From Intravenous (IV) to Subcutaneous (SC)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1921
https://www.valueinhealthjournal.com/article/S1098-3015(22)04126-2/fulltext
Title :
OP2 Organizational Impact Model Associated With Switching From Intravenous (IV) to Subcutaneous (SC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04126-2&doi=10.1016/j.jval.2022.09.1921
First page :
Section Title :
Open access? :
No
Section Order :
11477